HUE057494T2 - Anyagok és eljárások immunválaszok és a bõr és/vagy nyálkahártya gátfunkciójának javítására - Google Patents

Anyagok és eljárások immunválaszok és a bõr és/vagy nyálkahártya gátfunkciójának javítására

Info

Publication number
HUE057494T2
HUE057494T2 HUE16828408A HUE16828408A HUE057494T2 HU E057494 T2 HUE057494 T2 HU E057494T2 HU E16828408 A HUE16828408 A HU E16828408A HU E16828408 A HUE16828408 A HU E16828408A HU E057494 T2 HUE057494 T2 HU E057494T2
Authority
HU
Hungary
Prior art keywords
skin
materials
methods
immune responses
barrier function
Prior art date
Application number
HUE16828408A
Other languages
English (en)
Hungarian (hu)
Inventor
Eva Berkes
Nicholas Monsul
Frederick T Boehm
Original Assignee
Quorum Innovations Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quorum Innovations Llc filed Critical Quorum Innovations Llc
Publication of HUE057494T2 publication Critical patent/HUE057494T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/143—Fermentum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
HUE16828408A 2015-07-20 2016-07-19 Anyagok és eljárások immunválaszok és a bõr és/vagy nyálkahártya gátfunkciójának javítására HUE057494T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562194630P 2015-07-20 2015-07-20

Publications (1)

Publication Number Publication Date
HUE057494T2 true HUE057494T2 (hu) 2022-05-28

Family

ID=57835147

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16828408A HUE057494T2 (hu) 2015-07-20 2016-07-19 Anyagok és eljárások immunválaszok és a bõr és/vagy nyálkahártya gátfunkciójának javítására

Country Status (17)

Country Link
US (6) US9706778B2 (https=)
EP (1) EP3324986B1 (https=)
JP (1) JP6727285B2 (https=)
KR (1) KR102258415B1 (https=)
CN (1) CN108135947B (https=)
AU (1) AU2016297539B9 (https=)
BR (1) BR112018001187B1 (https=)
CA (1) CA2991990C (https=)
DK (1) DK3324986T3 (https=)
ES (1) ES2904555T3 (https=)
HU (1) HUE057494T2 (https=)
IL (1) IL256973B (https=)
MX (1) MX395076B (https=)
PL (1) PL3324986T3 (https=)
PT (1) PT3324986T (https=)
WO (1) WO2017015275A1 (https=)
ZA (1) ZA201800209B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
DK3324986T3 (da) * 2015-07-20 2022-01-31 Quorum Innovations Llc Materialer og fremgangsmåder til forbedring af immunreaktioner og hud- og/eller slimhindebarrierefunktion
WO2018146550A1 (en) 2017-02-10 2018-08-16 De Maio Domingos Mauricio Methods and systems for preventing, correcting, transforming, and modifying facial, aesthetics, and consulting patients regarding the same
US11253454B2 (en) * 2017-03-10 2022-02-22 Johnson & Johnson Consumer Inc. Method for affecting touch
GB201807576D0 (en) 2018-05-09 2018-06-20 Skinbiotherapeutics Plc Compositions and uses thereof
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3685669A1 (en) * 2019-01-23 2020-07-29 Chrisal NV Composition for the decontamination and inoculation of surfaces
EP3741398A1 (en) * 2019-05-20 2020-11-25 Medizinische Hochschule Hannover Method for coating a medical device and coated medical device
MX2022006163A (es) * 2019-11-26 2022-06-17 Quorum Innovations Llc Nuevas composiciones de barrera protectora y usos de las mismas.
CA3176797A1 (en) * 2020-05-06 2021-11-11 Nicholas T. Monsul Novel protein, and therapeutic and cosmetic uses thereof
KR102167387B1 (ko) * 2020-05-14 2020-10-19 코스맥스 주식회사 피부 장벽 강화, 피부 보습 또는 항노화를 위한 조성물
EP4161558A4 (en) * 2020-06-06 2024-06-19 Quorum Innovations, LLC Materials and methods for inhibiting a viral infection, including a coronavirus infection
CA3193765A1 (en) * 2020-09-29 2022-04-07 Anindya Dasgupta A personal care composition comprising amino acids
KR102573754B1 (ko) * 2021-02-25 2023-09-01 주식회사 차메디텍 신규의 펩타이드 및 이를 포함하는 피부장벽 강화 또는 피부가려움증 억제를 위한 화장료 조성물
KR102389749B1 (ko) * 2021-05-14 2022-04-22 주식회사 세바바이오텍 피부장벽강화 및 항주름 활성을 갖는 피부 유래 락토바실러스 퍼멘텀 아종 세바­１０１ 균주 및 이의 용도
CN113832050B (zh) * 2021-08-13 2022-10-21 广东省科学院微生物研究所(广东省微生物分析检测中心) 一株高效合成烟酰胺、抗光老化的发酵乳杆菌xjc60及其应用
CN114717162A (zh) * 2022-05-17 2022-07-08 廖梅香 发酵乳杆菌及其应用
CN118126875B (zh) * 2024-02-05 2024-11-05 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一株表皮葡萄球菌及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS057102A0 (en) * 2002-02-15 2002-03-07 Vri Biomedical Ltd Compositions and methods for treatment of skin disorders
US20050014729A1 (en) * 2003-07-16 2005-01-20 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
EP1736537A1 (en) * 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
JP2007284360A (ja) * 2006-04-13 2007-11-01 Mitsukan Group Honsha:Kk 乳酸菌由来のｐｐａｒ依存的遺伝子転写活性化組成物
RU2009125184A (ru) * 2006-12-01 2011-01-10 Органобэлэнс Гмбх (De) Композиции, наборы и их применения для защиты кожи от патогенных микроорганизмов
EP2227239A2 (en) * 2007-12-06 2010-09-15 Arla Foods Amba Probiotic bacteria and regulation of fat storage
CZ2009724A3 (cs) * 2009-11-04 2011-02-09 Bio Agens Research And Development - Bard, S.R.O. Protiplísnová smes s houbovým organismem Pythium oligandrum
AU2011241175A1 (en) * 2010-04-16 2012-11-29 Davos Life Science Pte. Ltd. Synergistic interaction of at least one Vitamin E component and tyrosinase inhibitors for dermatological applications
CN103415531B (zh) * 2011-02-09 2016-10-26 器官平衡有限责任公司 用于治疗皮肤病症的肽
CN103687604A (zh) 2011-03-01 2014-03-26 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
CN102226157B (zh) * 2011-05-06 2013-01-09 北京龙科方舟生物工程技术有限公司 一株发酵乳杆菌及其应用
KR20150000867A (ko) 2011-12-07 2015-01-05 칼피스가부시키가이샤 유산균 또는 그 처리물을 포함한 지질대사 및/또는 당대사 개선제
DK3324986T3 (da) * 2015-07-20 2022-01-31 Quorum Innovations Llc Materialer og fremgangsmåder til forbedring af immunreaktioner og hud- og/eller slimhindebarrierefunktion

Also Published As

Publication number Publication date
MX2018000870A (es) 2018-05-15
PL3324986T3 (pl) 2022-04-04
IL256973A (en) 2018-03-29
DK3324986T3 (da) 2022-01-31
US20230165915A1 (en) 2023-06-01
KR102258415B1 (ko) 2021-05-28
US20170020139A1 (en) 2017-01-26
US10617726B2 (en) 2020-04-14
US10004772B2 (en) 2018-06-26
CN108135947A (zh) 2018-06-08
MX395076B (es) 2025-03-24
US12440521B2 (en) 2025-10-14
KR20180023012A (ko) 2018-03-06
EP3324986A4 (en) 2019-01-09
US20260034184A1 (en) 2026-02-05
HK1253067A1 (zh) 2019-06-06
CN108135947B (zh) 2022-06-14
CA2991990C (en) 2024-04-16
AU2016297539B9 (en) 2019-11-28
EP3324986B1 (en) 2021-11-24
US20200215130A1 (en) 2020-07-09
US20170224748A1 (en) 2017-08-10
IL256973B (en) 2020-06-30
JP2018527322A (ja) 2018-09-20
EP3324986A1 (en) 2018-05-30
US11564957B2 (en) 2023-01-31
CA2991990A1 (en) 2017-01-26
US20170296599A1 (en) 2017-10-19
ZA201800209B (en) 2018-12-19
AU2016297539B2 (en) 2019-10-31
BR112018001187B1 (pt) 2022-02-15
PT3324986T (pt) 2022-01-26
BR112018001187A2 (pt) 2018-09-11
US9706778B2 (en) 2017-07-18
AU2016297539A1 (en) 2018-02-08
WO2017015275A1 (en) 2017-01-26
JP6727285B2 (ja) 2020-07-22
ES2904555T3 (es) 2022-04-05

Similar Documents

Publication Publication Date Title
HUE057494T2 (hu) Anyagok és eljárások immunválaszok és a bõr és/vagy nyálkahártya gátfunkciójának javítására
FIC20230014I1 (fi) Foslevodopa ja foskarbidopa
IL284348A (en) Hiv pre-immunization and immunotherapy
IL258931A (en) Therapeutic compounds and methods
EP3563863A4 (en) LYOPHILIZED PREPARATION
LT3368534T (lt) Valbenazino ditozilatas ir jo polimorfai
DK3393510T3 (da) Zikavirusvaccine
UY4533S (es) Tostadora
HUE055473T2 (hu) Difluormetil-aminopiridinek és difluormetil-aminopirimidinek
LT3280441T (lt) Anti-sortilino antikūnai ir jų naudojimo būdai
HUE045216T2 (hu) Anti-CD79B antitestek és alkalmazási eljárások
HUE052771T2 (hu) C10orf54 elleni antitestek és alkalmazásuk
LT3215532T (lt) Anti-tim3 antikūnai ir jų naudojimo būdai
GB201508074D0 (en) People detection
DK3152607T3 (da) En antiresonant hulkernefiber
HUE040395T2 (hu) Ápolóeszköz és eljárás
LT3550023T (lt) Oligomerai ir oligomerų konjugatai
HUE057726T2 (hu) Fehérje glikozilálására szolgáló készítmények és módszerek
DK3161139T3 (da) Tlr-4-specifikke aptamerer og anvendelser heraf
IL256381A (en) Cryoprecipitate compositions and methods of preparation thereof
EP3385286A4 (en) VACCINE FANTASY WITH INCREASED IMMUNOGENITY
LT3169307T (lt) Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną
DK3458080T3 (da) Polypeptidmodulerende siglec-afhængige immunreaktioner
PT3365321T (pt) Zwiterião de solabegron e suas utilizações
LT3337506T (lt) Deriniai ir jų panaudojimas